tiprankstipranks
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Compare Everest Medicines Ltd. (1952) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$51.50
HK$13.47B
-38.53
-17.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$11.75
HK$22.49B
31.11
81.98%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$10.74B
30.77
58.83%
Keymed Biosciences, Inc.
HK$62.80
HK$21.06B
-25.84
83.82%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.55B
-77.24
66.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$9.48B
20.83
-6.75%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
38.10
-12.15
-24.18%
HK:9969
InnoCare Pharma Ltd.
15.05
6.41
74.19%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.78
1.61
38.61%
HK:2162
Keymed Biosciences, Inc.
75.00
29.70
65.56%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.24
5.42
42.28%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
22.38
-1.46
-6.12%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts